Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death
about
Lymphoma: immune evasion strategiesAmplification of Fas-mediated apoptosis in type II cells via microdomain recruitment.Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway.FLIP: a novel regulator of macrophage differentiation and granulocyte homeostasisMolecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma.The role of cellular FLICE inhibitory protein (c-FLIP) in the pathogenesis and treatment of cancer.EBV in Hodgkin Lymphoma.KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.A New Player in the Development of TRAIL Based Therapies for Hepatocarcinoma Treatment: ATM Kinase.The role of c-FLIP splice variants in urothelial tumours.4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells.Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea.RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NF-κB Activation and Lymphoma Survival.Targeting cellular FLICE-like inhibitory protein as a novel approach to the treatment of Hodgkin's lymphoma.Hodgkin's lymphoma: molecular targets and novel treatment strategies.Novel therapies for Hodgkin Lymphoma.Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma.c-FLIP knockdown induces ligand-independent DR5-, FADD-, caspase-8-, and caspase-9-dependent apoptosis in breast cancer cells.Utilizing cell-based therapeutics to overcome immune evasion in hematologic malignancies.FLIP as an anti-cancer therapeutic target.Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment.Rocaglamide and a XIAP inhibitor cooperatively sensitize TRAIL-mediated apoptosis in Hodgkin's lymphomas.CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.Loss of expression of LyGDI (ARHGDIB), a rho GDP-dissociation inhibitor, in Hodgkin lymphoma.IkappaBalpha independent induction of NF-kappaB and its inhibition by DHMEQ in Hodgkin/Reed-Sternberg cells.FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis.Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis.C/EBPalpha or C/EBPalpha oncoproteins regulate the intrinsic and extrinsic apoptotic pathways by direct interaction with NF-kappaB p50 bound to the bcl-2 and FLIP gene promoters.Endothelial expression of TNF receptor-1 generates a proapoptotic signal inhibited by integrin α6β1 in glioblastoma.Inhibition of methionine adenosyltransferase II induces FasL expression, Fas-DISC formation and caspase-8-dependent apoptotic death in T leukemic cells.Chromosomal Instability in Hodgkin Lymphoma: An In-Depth Review and Perspectives.Apoptosis-resistant phenotype of classical Hodgkin's lymphoma is not mediated by somatic mutations within genes encoding members of the death-inducing signaling complex (DISC).cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy
P2860
Q28080705-8E08D196-8A38-4840-A0F7-8E6770F453AAQ33925187-E32EB45F-DB0D-4B17-9390-F662E7C7E188Q34378553-64B24D0A-04C0-4FED-833E-D9EE03F8BC49Q34450721-0300E33C-76F5-4FEA-AB6B-125EEE8F6028Q34480682-47054399-AC67-461F-B65C-E5A1520B8FAAQ34488806-C2915B66-9BB3-46B6-BC38-48C43DACBF8DQ34549468-88202B9E-AEAC-46BF-B832-648DF50BF7B0Q34805471-B386780D-B0EF-4786-BBC1-37C7B2C54961Q35038107-64B2ED84-9EEF-4DD5-AF14-4C4838EFFBB1Q35657114-74F7C8FD-EF68-4400-A647-003C2F756E8CQ35668904-AD601249-DDA3-43FB-A460-CD7AF77E2FB1Q35785249-368AFC55-7821-4AED-BEAC-12B38E184186Q36033375-30A90690-A717-4A9C-A625-EE8560C6A882Q36500552-1EB21E54-B4EB-44B6-B7F7-B71A0975926EQ36572545-ACA8C64F-5E35-44DD-8809-AA7949F0492CQ36612532-FCE5A7AC-B8DC-4099-AE9A-723C24AA758EQ37004635-6DECFEF1-6F51-41D1-AF53-E7B8FD5100ADQ37016499-AEFCA6EC-1681-4D66-A3DB-FC9FA8342818Q37029417-ABB9F0A1-77E4-452C-9F53-CF05C5BE26D5Q37058110-AAB6F1A8-276A-49C8-96AB-E1BC3B01D5C8Q37096732-6BD77005-1615-4BA4-AE4B-11B080FD96DAQ37271829-80BD8952-1703-4374-AD16-02E61C900A2AQ39467184-1F7C697C-AF60-4295-BBBB-F7BE1F870224Q40056601-05448625-CE09-488A-BCA1-337089549553Q40076005-DD2628EB-4712-40C6-BCF0-BBD65D231BD5Q40169298-455C9C54-26FF-43CF-A027-3F35FB1527D4Q40428505-EEFDBEDE-9187-47FD-B351-B097A88230EFQ40448034-5E92019B-9ADB-45AA-A1A3-BC353354B1BAQ41839749-124B12C3-66DA-4241-A386-55E230D253A8Q42321360-8121549A-64F2-40B8-AC4C-4DA05ADDAB26Q46220088-74719E07-BA4A-4654-9538-9A09B9DF422DQ52340211-A6BB2BFD-330C-46B8-B7BF-B6D8464C42D5Q53861687-049ADC3E-08CC-4EAB-A3EC-DCD87E313A13Q57201231-84D236A2-4C27-4F4E-BF43-F3482508F334
P2860
Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Expression of the cellular FLI ...... autonomous Fas-mediated death
@ast
Expression of the cellular FLI ...... autonomous Fas-mediated death
@en
type
label
Expression of the cellular FLI ...... autonomous Fas-mediated death
@ast
Expression of the cellular FLI ...... autonomous Fas-mediated death
@en
prefLabel
Expression of the cellular FLI ...... autonomous Fas-mediated death
@ast
Expression of the cellular FLI ...... autonomous Fas-mediated death
@en
P2093
P2860
P356
P1476
Expression of the cellular FLI ...... autonomous Fas-mediated death
@en
P2093
A E Milner
G M Reynolds
J D O'Neil
J Starczynski
P G Murray
P2860
P304
P356
10.1073/PNAS.0400765101
P407
P577
2004-04-19T00:00:00Z